Brightside Health, a provider of teletherapy services for depression, anxiety, and other mood disorders, has successfully raised $33 million in Series C funding. The round was led by S32 and included both existing and new investors such as Kennedy Lewis, Time BioVentures, and Anne Wojcicki’s Redwood Pacific. This funding will support Brightside Health’s ongoing expansion, including its recent move into Medicaid and Medicare programs and the development of its Crisis Care program for individuals at risk of suicide. With one in five adults in the US experiencing mental health conditions, the company’s comprehensive approach to mental healthcare meets a significant need. Brightside’s services, including precision psychiatry and clinically proven therapy, are available in all 50 states for a variety of payment options and are expanding to reach even more individuals.


San Francisco, CA – Brightside Health, a pioneering company in the telemental health sector, has successfully secured $33 million in Series C funding, elevating the company's total financial backing to a commendable $100 million. The latest funding round was spearheaded by the esteemed S32, with Trip Hofer being appointed to the Board of Directors. Esteemed contributors to this round include Kennedy Lewis, Time BioVentures, Anne Wojcicki's Redwood Pacific, along with returning investors such as ACME, Mousse Partners, and Triventures.

The infusion of new capital marks a significant milestone for Brightside Health, reinforcing its mission to deliver comprehensive mental healthcare to individuals facing mild to severe clinical depression, anxiety, and other mood disorders. The funding will predominantly be utilized to bolster the company's operational capabilities and extend its reach into new markets, thereby democratizing access to quality mental healthcare.

Under the leadership of CEO Brad Kittredge, Brightside Health has distinguished itself in the healthcare sector through its innovative use of proprietary AI and purpose-built technology. This technological foundation, combined with a network of skilled clinicians, allows the company to offer precision psychiatry alongside effective therapeutic techniques, significantly enhancing patient outcomes on a broad scale.

Brightside Health’s model is designed to cater to a wide range of needs, providing care to people with elevated suicide risk, among other conditions. Significantly, the services provided by Brightside are accessible and insurance-reimbursable across all 50 states and D.C., with the promise of appointments available in less than 48 hours—demonstrating a commitment to timely and effective care.

As the demand for mental health services continues to rise, Brightside Health's recent financial achievement not only solidifies its standing in the market but also underscores the growing recognition of teletherapy's potential to revolutionize mental health care delivery. For more information about Brightside Health and its services, visit https://www.brightside.com/.